Jasmina Isaković

Dr. Jasmina Isaković

Omnion Research International Ltd.
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
JIJasmina Isaković
Jasmina Isaković
KŠKlara Šerer
Klara Šerer
BBBarbara Barišić
Barbara Barišić
DMDinko Mitrečić
Dinko Mitrečić
Neurological disorders are recognized as major causes of death and disability worldwide. Because of this, they represent one of the largest public health challenges. With awareness of the massive burden associated with these disorders, came the recognition that treatment options were disproportionately scarce and, oftentimes, ineffective. To address these problems, modern research is increasingly looking into novel, more effective methods to treat neurological patients; one of which is cell-based therapies. In this review, we present a critical analysis of the features, challenges, and prospects of one of the stem cell types that can be employed to treat numerous neurological disorders—mesenchymal stem cells (MSCs). Despite the fact that several studies have already established the safety of MSC-based treatment approaches, there are still some reservations within the field regarding their immunocompatibility, heterogeneity, stemness stability, and a range of adverse effects—one of which is their tumor-promoting ability. We additionally examine MSCs’ mechanisms of action with respect toin vitroandin vivoresearch as well as detail the findings of past and ongoing clinical trials for Parkinson’s and Alzheimer’s disease, ischemic stroke, glioblastoma multiforme, and multiple sclerosis. Finally, this review discusses prospects for MSC-based therapeutics in the form of biomaterials, as well as the use of electromagnetic fields to enhance MSCs’ proliferation and differentiation into neuronal cells.

21 April 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
JIJasmina Isaković
Jasmina Isaković
IŠIva Šimunić
Iva Šimunić
DJDenis Jagecic
Denis Jagecic
VHValentina Hribljan
Valentina Hribljan
DMDinko Mitrecic
Dinko Mitrecic
Neural tube defects (NTDs) are the second most common congenital malformations of humans, characterized by impaired development of the central nervous system. Even though the etiology of most birth defects remains undetermined, genetic and environmental risk factors in the background of NTDs have been identified and extensively reported. On top of genetic and nutritional risks which include mutations in both coding and non-coding regions and maternal folate status, respectively, recent years have seen a rise in the identification of a variety of teratogens that could be implicated in NTD development. These include polycyclic aromatic hydrocarbons, arsenic, pesticides, maternal hyperthermia and antibiotics as well as pain and seizure medication. With an increase in understanding of teratogens leading to NTD formation, preventative and treatment approaches have witnessed great advances throughout the years. While the most common preventative approach includes folic acid food fortification as well as suggested inositol supplementation, treatment and management approaches differ greatly depending on the developmental stage and the site of the lesion and include prenatal surgery, stem cell transplantation and postnatal surgery. Because NTDs still represent a large health and financial burden for the patient and society as a whole, it is crucial to investigate potential risk factors and develop novel approaches in order to fully prevent this category of disorders.

27 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JIJasmina Isaković
Jasmina Isaković
IDIan Dobbs-Dixon
Ian Dobbs-Dixon
DCDipesh Chaudhury
Dipesh Chaudhury
DMDinko Mitrecic
Dinko Mitrecic
All major processes in the nervous system depend on interactions between cells and nerve fibers. In this work we present a novel model of inhomogeneous electromagnetic fields originating from nerve fibers and delineate their influence on cells. By expanding Hodgkin-Huxley’s applied current into axial current, governed by $${J}_{i}^{j+1}=K\times {J}_{i}^{j}$$ J i j + 1 = K × J i j , we reveal that cell-with-neuron interactions are regulated by the strength of the electromagnetic fields, which are homogeneous up to 2.066 μm or 6.606 μm away from neurilemma and axolemma, respectively. At the nodes of Ranvier, these fields reach strengths of 3.0 × 10−12T, while at the myelinated segments they only peak at 2.3 × 10−12T. These are the same fields which are, due to inhomogeneity, detected as 1,000 times weaker by magnetoencephalography. Considering the widespread occurrence of neurodegenerative disorders, our model reveals that a 50% demyelination increases the field strength by 0.35 × 10−12T, while a complete demyelination increases it by 0.7 × 10−12T. Since this suggests that the inhomogeneous electromagnetic fields around neurons play a role in physiological and pathological processes, including cell-to-neuron and cell-to-cell communication, their improved understanding opens up new therapeutic strategies based on electromagnetic field modulation or cell’s surface charge alteration.

1 April 2019 in Croatian Medical Journal
Verified
Journal Article
Open access
JIJasmina Isaković
Jasmina Isaković
DGDunja Gorup
Dunja Gorup
DMDinko Mitrecic
Dinko Mitrecic
To propose potential mechanisms of action of electromagnetic fields (EMF) on astrocytes and microglia and to elucidate the role of heat shock proteins (HSP), adenosine triphosphate (ATP), calcium ions (Ca[2+] ), and hypoxia-inducible factor 1α ...

Verified
Journal Article
Open access
PDF file
DMDinko Mitrecic
Dinko Mitrecic
VHValentina Hribljan
Valentina Hribljan
DJDenis Jagecic
Denis Jagecic
JIJasmina Isaković
Jasmina Isaković
FLFederica Lamberto
Federica Lamberto
ADAndrás Dinnyés
András Dinnyés
From the first success in cultivation of cells in vitro, it became clear that developing cell and/or tissue specific cultures would open a myriad of new opportunities for medical research. Expertise in various in vitro models has been developing over decades, so nowadays we benefit from highly specific in vitro systems imitating every organ of the human body. Moreover, obtaining sufficient number of standardized cells allows for cell transplantation approach with the goal of improving the regeneration of injured/disease affected tissue. However, different cell types bring different needs and place various types of hurdles on the path of regenerative neurology and regenerative cardiology. In this review, written by European experts gathered in Cost European action dedicated to neurology and cardiology-Bioneca, we present the experience acquired by working on two rather different organs: the brain and the heart. When taken into account that diseases of these two organs, mostly ischemic in their nature (stroke and heart infarction), bring by far the largest burden of the medical systems around Europe, it is not surprising that in vitro models of nervous and heart muscle tissue were in the focus of biomedical research in the last decades. In this review we describe and discuss hurdles which still impair further progress of regenerative neurology and cardiology and we detect those ones which are common to both fields and some, which are field-specific. With the goal to elucidate strategies which might be shared between regenerative neurology and cardiology we discuss methodological solutions which can help each of the fields to accelerate their development.

1 November 2020 in Neuroscience Letters
Verified
Journal Article
Closed access
GTGerardo Tricarico
Gerardo Tricarico
JIJasmina Isaković
Jasmina Isaković
MSMin Suk Song
Min Suk Song
FRFranco Rustichelli
Franco Rustichelli
VTValter Travagli
Valter Travagli
DMDinko Mitrecic
Dinko Mitrecic